Reduction malarplasty using osteotomy and repositioning of the malar complex: clinical review and comparison of two techniques.
Twenty-five patients with a prominent zygoma underwent reduction malarplasty from January 1995 through January 2001.
- 추적기간 13 months
APA
Cho BC (2003). Reduction malarplasty using osteotomy and repositioning of the malar complex: clinical review and comparison of two techniques.. The Journal of craniofacial surgery, 14(3), 383-92. https://doi.org/10.1097/00001665-200305000-00019
MLA
Cho BC. "Reduction malarplasty using osteotomy and repositioning of the malar complex: clinical review and comparison of two techniques.." The Journal of craniofacial surgery, vol. 14, no. 3, 2003, pp. 383-92.
PMID
12826810
Abstract
Twenty-five patients with a prominent zygoma underwent reduction malarplasty from January 1995 through January 2001. In mild cases, the osteotomized zygoma was repositioned superoposteriorly. In severe cases, after the removal of a 2- to 5-mm-thick bony segment, the osteotomized zygoma was repositioned medially and superoposteriorly. Ten patients underwent reduction malarplasty based on a bicoronal incision, whereas intraoral and preauricular incisions were used in the other 15 cases. Ten patients were male and 15 patients were female, with an age range from 18 to 52 years. The average follow-up was 13 months. All patients were satisfied with their results, and a symmetrical appearance was achieved in all cases. Reduction malarplasty using a bicoronal incision has various advantages because it provides a wide operative field, makes it easy to maintain symmetry, and facilitates combination with a forehead lift. Conversely, reduction malarplasty using an intraoral and preauricular incision has the advantages of a short operative time, simple procedure, and no scalp scar. Because the whole face should be regarded as one unit, the following adjutant procedures were also performed simultaneously: reduction of the mandibular angle in 17 patients, augmentation rhinoplasty in 4 patients, face lift in 2 patients, and fat graft in 2 patients. In conclusion, the procedure of osteotomy and repositioning the malar complex was found to be effective for correcting a prominent malar complex.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | malar
|
광대뼈 | dict | 3 | |
| 해부 | zygoma
|
광대뼈 | dict | 3 | |
| 시술 | rhinoplasty
|
코성형술 | dict | 1 | |
| 시술 | face lift
|
안면거상술 | dict | 1 | |
| 해부 | intraoral
|
scispacy | 1 | ||
| 해부 | mandibular
|
scispacy | 1 | ||
| 해부 | fat graft
|
scispacy | 1 | ||
| 합병증 | preauricular incisions
|
scispacy | 1 | ||
| 합병증 | forehead lift
|
scispacy | 1 | ||
| 합병증 | preauricular incision
|
scispacy | 1 | ||
| 합병증 | scalp scar
|
scispacy | 1 |
MeSH Terms
Adolescent; Adult; Esthetics; Female; Humans; Male; Mandible; Osteotomy; Plastic Surgery Procedures; Treatment Outcome; Zygoma
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (5)
- Free latissimus dorsi muscle transfer using an endoscopic technique.
- MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancer.
- Response to the Letter to the Editor: "Lazertinib in EGFR-Mutated NSCLC with CNS Metastases: Reinforcing the Role of Third-Generation TKIs through Pooled Analysis".
- Durvalumab Plus Chemotherapy in Patients With -Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARD.
- Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Aesthetically ideal noses created using a single artificial intelligence model: Validating literature and exploring ethnic differences.
- Septocolumellar strut technique: Tip stability and aesthetic outcomes in rhinoplasty.
- Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.
- Clinical safety of a low-modification hyaluronic acid filler (MoD 2%) for facial rejuvenation.